Ahmed Mohamed Mossad

Ahmed Mohamed Mossad

Auto-generated profile, based on publicly available information

Ahmed Mohamed Mossad

Department of Internal medicine and Endocrinology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 November 2024 in Suez Canal University Medical Journal
Verified
Journal Article
Closed access
RMRana Belal Mohammad
Rana Belal Mohammad
AMAhmed Mohamed Mossad
Ahmed Mohamed Mossad
OLOla Farouk Leheta
Ola Farouk Leheta
AHAnn Hegazy Ali Hegazy
Ann Hegazy Ali Hegazy
Background:Diabetic nephropathy is considered a main microvascular complication of diabetes mellitus (DM) that results in chronic renal failure. Fatty acid-binding protein 1 (FABP1) is expressed in renal proximal tubule cells and released into urine as a result of hypoxia triggered by decreased peritubular capillary blood flow, consequently urinary FABP1 is seen as a hopeful indicator for monitoring tubulointerstitial injury. There is increasing evidence that FABP1 plays a role in the development and progression of chronic kidney disease. Aim: This study aimed to assess the correlation of circulating plasma FABP1 level as well as its urinary level to nephropathy in patients with type 2 diabetes mellitus.Methods: Ninety patients were recruited, divided into 3 groups. They were investigated for glycemic and renal biomarkers, then FABP1 concentration was measured in their serum and urine samples. Bioinformatic analysis was done to explore the relation between FABP1 and DN. Results: The presence of DN was associated with increase in both serum and urinary FABP1. A serum FABP1 concentration of >243 ng/L was associated with DN, with a sensitivity of 93% and specificity of 90%, while urinary FABP1 concentration of >155.67 ng/L was associated with DN, with a sensitivity of 90% and specificity of 73%. Bioinformatic analysis revealed interactions between FABP1 and other kidney markers. Conclusion: This study proved that serum and urinary levels of FABP1 were significantly higher in the DN group than the normo-albuminuric groups reflecting the progression of the disease, thus they can be used as diagnostic biomarkers with significant sensitivity and specificity.